Utrecht Holdings
Overview
Utrecht Holdings is the knowledge transfer office and early-stage investor for Utrecht University and University Medical Center Utrecht, focused on commercializing scientific research by creating and investing in spin-off companies in sectors including life sciences, digital innovation, and sustainability.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| UCANACT | Sep 2026 | Pre Seed | Lead |
| CryoCloud | May 2025 | Seed | Co-investor |
| Lumox | Mar 2024 | Grant | Co-investor |
| Cordys Analytics | Oct 2023 | Seed | Lead |
| TargED Biopharmaceuticals | Feb 2022 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Utrecht Holdings based?
Utrecht Holdings is headquartered in Utrecht, Netherlands.
When was Utrecht Holdings founded?
Utrecht Holdings was founded in 1998.
How many portfolio companies does Utrecht Holdings have?
Utrecht Holdings has 10 portfolio companies in Caplight's dataset.
What are some companies in Utrecht Holdings's portfolio?
Recent investments visible on Caplight include UCANACT, CryoCloud, Lumox, Cordys Analytics, TargED Biopharmaceuticals.
What was Utrecht Holdings's most recent investment?
Utrecht Holdings's most recent investment on Caplight was in UCANACT in 2026.
What sectors does Utrecht Holdings focus on?
Utrecht Holdings focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does Utrecht Holdings focus on?
Utrecht Holdings typically invests at the Early stage.